Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis

被引：196

作者：

Furue, M. ^{[1
,2
,3
]}

Yamamura, K. ^{[1
,2
]}

Kido-Nakahara, M. ^{[1
,2
]}

Nakahara, T. ^{[1
,2
]}

Fukui, Y. ^{[4
,5
]}

机构：

[1] Kyushu Univ, Dept Dermatol, Grad Sch Med Sci, Fukuoka, Japan

[2] Kyushu Univ, Div Skin Surface Sensing, Grad Sch Med Sci, Fukuoka, Japan

[3] Kyushu Univ, Res & Clin Ctr Yusho & Dioxin, Kyushu Univ Hosp, Fukuoka, Japan

[4] Kyushu Univ, Med Inst Bioregulat, Div Immunogenet, Dept Immunobiol & Neurosci, Fukuoka, Japan

[5] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka, Japan

来源：

ALLERGY | 2018年 / 73卷 / 01期

关键词：

atopic dermatitis; interleukin-31; receptor; pruritus; T helper 2; IL-31; MONOCLONAL-ANTIBODY; CLIENT-OWNED DOGS; T-CELLS; ONCOSTATIN-M; LOKIVETMAB ZTS-00103289; SKIN INFLAMMATION; RELEASE IL-31; DOUBLE-BLIND; ITCH; PLACEBO;

D O I：

10.1111/all.13239

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (T(H)2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from T(H)2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.

引用

页码：29 / 36

页数：8

共 77 条

[1] IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis [J].

Bilsborough, J ;

Leung, DYM ;

Maurer, M ;

Howell, M ;

Boguniewcz, M ;

Yao, L ;

Storey, H ;

LeCiel, C ;

Harder, B ;

Gross, JA .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) :418-425

[2] IL-31 Receptor (IL-31RA) Knockout Mice Exhibit Elevated Responsiveness to Oncostatin M [J].

Bilsborough, Janine ;

Mudri, Sherri ;

Chadwick, Eric ;

Harder, Brandon ;

Dillon, Stacey R. .

JOURNAL OF IMMUNOLOGY, 2010, 185 (10) :6023-6030

[3] Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial [J].

Bissonnette, R. ;

Papp, K. A. ;

Poulin, Y. ;

Gooderham, M. ;

Raman, M. ;

Mallbris, L. ;

Wang, C. ;

Purohit, V. ;

Mamolo, C. ;

Papacharalambous, J. ;

Ports, W. C. .

BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) :902-911

[4] Toll-like receptor-4 signaling mediates pulmonary neutrophil sequestration in response to gram-positive bacterial enterotoxin [J].

Calkins, CM ;

Barsness, K ;

Bensard, DD ;

Vasquez-Torres, A ;

Raeburn, CD ;

Meng, XZ ;

McIntyre, RC .

JOURNAL OF SURGICAL RESEARCH, 2002, 104 (02) :124-130

[5] A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1 [J].

Cevikbas, Ferda ;

Wang, Xidao ;

Akiyama, Tasuku ;

Kempkes, Cordula ;

Savinko, Terhi ;

Antal, Attila ;

Kukova, Gabriela ;

Buhl, Timo ;

Ikoma, Akihiko ;

Buddenkotte, Joerg ;

Soumelis, Vassili ;

Feld, Micha ;

Alenius, Harri ;

Dillon, Stacey R. ;

Carstens, Earl ;

Homey, Bernhard ;

Basbaum, Allan ;

Steinhoff, Martin .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) :448-+

[6] The price of pruritus - Sleep disturbance and cosleeping in atopic dermatitis [J].

Chamlin, SL ;

Mattson, CL ;

Frieden, IJ ;

Williams, ML ;

Mancini, AJ ;

Cella, D ;

Chren, MM .

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2005, 159 (08) :745-750

[7] Eccrine Sweat Contains IL-1α, IL-1β and IL-31 and Activates Epidermal Keratinocytes as a Danger Signal [J].

Dai, Xiuju ;

Okazaki, Hidenori ;

Hanakawa, Yasushi ;

Murakami, Masamoto ;

Tohyama, Mikiko ;

Shirakata, Yuji ;

Sayama, Koji .

PLOS ONE, 2013, 8 (07)

[8] Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice [J].

Dillon, SR ;

Sprecher, C ;

Hammond, A ;

Bilsborough, J ;

Rosenfeld-Franklin, M ;

Presnell, SR ;

Haugen, HS ;

Maurer, M ;

Harder, B ;

Johnston, J ;

Bort, S ;

Mudri, S ;

Kuijper, JL ;

Bukowski, T ;

Shea, P ;

Dong, DL ;

Dasovich, M ;

Grant, FJ ;

Lockwood, L ;

Levin, SD ;

LeCiel, C ;

Waggie, K ;

Day, H ;

Topouzis, S ;

Kramer, J ;

Kuestner, R ;

Chen, Z ;

Foster, D ;

Parrish-Novak, J ;

Gross, JA .

NATURE IMMUNOLOGY, 2004, 5 (07) :752-760

[9]

Diveu C, 2004, EUR CYTOKINE NETW, V15, P291

[10] Characterization of the signaling capacities of the novel gp130-like cytokine receptor [J].

Dreuw, A ;

Radtke, S ;

Pflanz, S ;

Lippok, BE ;

Heinrich, PC ;

Hermanns, HM .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (34) :36112-36120

← 1 2 3 4 5 6 7 8 →